2018 annual financial data
Neuphoria Therapeutics 2018 Operating margin
Direct answer
Operating margin was -178.18%.
Operating income was -21.28M USD and net income was -18.43M USD.
Operating cash flow was -15.02M USD.
Get free Neuphoria Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 11.94M USD
- Operating income
- -21.28M USD
- Net income
- -18.43M USD
- Operating cash flow
- -15.02M USD